Reid Bissonnette

Lead Scientist, Immuno-Oncology at Targazyme

Reid Bissonnette is an experienced professional in the field of Immuno-Oncology, Oncology, and Immunology. Currently serving as a Consultant at Xenetic Biosciences, Inc. and Radionetics Oncology, as well as holding advisory roles at Circulants and Demigos. Previously, Reid held the position of Vice President of Immuno-Oncology at TargaZyme, Inc. with a background in Pharmacology and Oncology Drug Discovery and Development. With a PhD in Tumor Immunology and Cellular Immunology from McGill University, Reid's expertise is highly valuable in the pharmaceutical industry.

Links

Previous companies

Aristea Therapeutics logo
Ligand Pharmaceuticals logo
ArriVent Biopharma logo

Org chart